skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Result Number Material Type Add to My Shelf Action Record Details and Options
1
High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants
Material Type:
Article
Add to My Research

High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants

Journal of the American College of Cardiology, 2017-08, Vol.70 (5), p.558-568 [Peer Reviewed Journal]

2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 1, 2017 ;2017 The Authors 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.05.062 ;PMID: 28750699

Full text available

2
N-Terminal Pro-Brain Natriuretic Peptide Is a More Useful Predictor of Cardiovascular Disease Risk Than C-Reactive Protein in Older Men With and Without Pre-Existing Cardiovascular Disease
Material Type:
Article
Add to My Research

N-Terminal Pro-Brain Natriuretic Peptide Is a More Useful Predictor of Cardiovascular Disease Risk Than C-Reactive Protein in Older Men With and Without Pre-Existing Cardiovascular Disease

Journal of the American College of Cardiology, 2011-06, Vol.58 (1), p.56-64 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2011 American College of Cardiology Foundation ;2015 INIST-CNRS ;Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 28, 2011 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2011.02.041 ;PMID: 21700090 ;CODEN: JACCDI

Full text available

3
HIGH SERUM IMMUNOGLOBULIN G AND M LEVELS IMPROVE CARDIOVASCULAR RISK DISCRIMINATION IN HYPERTENSION: A NESTED CASE-CONTROL SUBSTUDY OF THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL
Material Type:
Article
Add to My Research

HIGH SERUM IMMUNOGLOBULIN G AND M LEVELS IMPROVE CARDIOVASCULAR RISK DISCRIMINATION IN HYPERTENSION: A NESTED CASE-CONTROL SUBSTUDY OF THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.1912-1912 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2016 American College of Cardiology Foundation ;Copyright Elsevier Limited Apr 5, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(16)31913-1

Full text available

4
Evaluation of C-Reactive Protein Before and On-Treatment as a Predictor of Benefit of Atorvastatin
Material Type:
Article
Add to My Research

Evaluation of C-Reactive Protein Before and On-Treatment as a Predictor of Benefit of Atorvastatin

Journal of the American College of Cardiology, 2013-08, Vol.62 (8), p.717-729 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2013 American College of Cardiology Foundation ;Copyright Elsevier Limited Aug 20, 2013 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2013.02.098

Full text available

5
MULTIPLE CARDIAC BIOMARKERS TO OPTIMISE PREDICTION OF CARDIOVASCULAR EVENTS IN THE GENERAL POPULATION
Material Type:
Article
Add to My Research

MULTIPLE CARDIAC BIOMARKERS TO OPTIMISE PREDICTION OF CARDIOVASCULAR EVENTS IN THE GENERAL POPULATION

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.1857-1857 [Peer Reviewed Journal]

2023 American College of Cardiology Foundation ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(23)02301-X

Full text available

6
Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time
Material Type:
Article
Add to My Research

Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time

Journal of the American College of Cardiology, 2020-03, Vol.75 (12), p.1406-1421 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020 The Authors 2020 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.01.041 ;PMID: 32216909

Full text available

7
GROWTH DIFFERENTIATION FACTOR-15, CLINICAL OUTCOMES, AND THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: INSIGHTS FROM THE DAPA-HF TRIAL
Material Type:
Article
Add to My Research

GROWTH DIFFERENTIATION FACTOR-15, CLINICAL OUTCOMES, AND THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: INSIGHTS FROM THE DAPA-HF TRIAL

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.631-631 [Peer Reviewed Journal]

2023 American College of Cardiology Foundation ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(23)01075-6

Full text available

8
CA125 IN PATIENTS WITH HFREF AND THE EFFECT OF DAPAGLIFLOZIN: INSIGHTS FROM DAPA-HF
Material Type:
Article
Add to My Research

CA125 IN PATIENTS WITH HFREF AND THE EFFECT OF DAPAGLIFLOZIN: INSIGHTS FROM DAPA-HF

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.618-618 [Peer Reviewed Journal]

2023 American College of Cardiology Foundation ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(23)01062-8

Full text available

9
Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure
Material Type:
Article
Add to My Research

Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure

Journal of the American College of Cardiology, 2023-07, Vol.82 (2), p.142-157 [Peer Reviewed Journal]

2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2023.05.011 ;PMID: 37407113

Full text available

10
Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm
Material Type:
Article
Add to My Research

Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm

Journal of the American College of Cardiology, 2013-08, Vol.62 (8), p.717-729 [Peer Reviewed Journal]

Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2013.02.098 ;PMID: 23948514

Full text available

11
CURRENT SMOKING, MICROVASCULAR PATHOLOGY AND ADVERSE OUTCOME AFTER ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: NEW PATHOPHYSIOLOGICAL INSIGHTS
Material Type:
Article
Add to My Research

CURRENT SMOKING, MICROVASCULAR PATHOLOGY AND ADVERSE OUTCOME AFTER ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: NEW PATHOPHYSIOLOGICAL INSIGHTS

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.175-175 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2017 American College of Cardiology Foundation ;Copyright Elsevier Limited Mar 21, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(17)33564-7

Full text available

12
Evaluation of C-Reactive Protein Before and On-Treatment as a Predictor of Benefit of Atorvastatin: A Cohort Analysis From the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm : CARDIOMETABOLIC RISK
Material Type:
Article
Add to My Research

Evaluation of C-Reactive Protein Before and On-Treatment as a Predictor of Benefit of Atorvastatin: A Cohort Analysis From the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm : CARDIOMETABOLIC RISK

Journal of the American College of Cardiology, 2013, Vol.62 (8), p.717-729 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;CODEN: JACCDI

Full text available

13
N-Terminal Pro-Brain Natriuretic Peptide Is a More Useful Predictor of Cardiovascular Disease Risk Than C-Reactive Protein in Older Men With and Without Pre-Existing Cardiovascular Disease: Biomarkers
Material Type:
Article
Add to My Research

N-Terminal Pro-Brain Natriuretic Peptide Is a More Useful Predictor of Cardiovascular Disease Risk Than C-Reactive Protein in Older Men With and Without Pre-Existing Cardiovascular Disease: Biomarkers

Journal of the American College of Cardiology, 2011-06, Vol.58 (1), p.56-64 [Peer Reviewed Journal]

ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2011.02.041

Full text available

Searching Remote Databases, Please Wait